precision medicine. Due to a lack of statistically rigorous approaches and training data, differentiating driver mutations from passenger mutations remains a major challenge in cancer research. We develope a novel…
Driver mutations are a special type of genetic alterations that are causally correlated with oncogenesis. Accurate detection of the presence of driver mutations is extremely useful for early cancer diagnosis ... BRAF…
challenges in bioinformatics is to find the distinction between driver mutations that lead to tumorigenesis and random passenger mutations, which are known to be neutral and does not play
known as p.I49T: ATC>ACC) in familial cancer and its potential as a targetable driver mutation in carcinogenesis. Method: Germline mutational analysis was done using commercially available next generation sequencing…
genes that were differentially expressed. When the latter were compared to the 140 driver mutations in all cancers, 26 drivers had changes in expression levels among patients who developed ... epigenetic changes in…
protein mutations. The personalized approach to treatment of cancer calls for determining cancer ?driver? mutations for each tumor. The combinatorial diversity of cancer-driving events limits the applicability of…
sequencing revealed somatic mutations in 20 (83%) of 24 cases. Five harbored known cancer driver mutations in ARID1A, PIK3CA, KRAS, or PPP2R1A. Targeted sequencing uncovered KRAS mutations ... additional cases. Taken…
Even though numerous previous investigations had shed fresh light on somatic driver mutations in cancer tissues, the mutation-driven malignant transformation mechanism from normal to cancerous tissues remains still…
aspects and approaches of cancer precision treatments along with a brief explanation regarding study driver mutations and role of genomics and how a few personalized medications applications of the precision
Determining whether recurrent but rare cancer mutations are bona fide driver mutations remains a bottleneck in cancer research. Here we present the most comprehensive analysis of retrovirus driven lymphomagenesis…
Determining whether recurrent but rare cancer mutations are bona fide driver mutations remains a bottleneck in cancer research. Here we present the most comprehensive analysis of retrovirus driven lymphomagenesis…
cancer research today and is predicated on weeding out ‘bystander’ mutation and identifying the ‘driver’ mutations and pathways responsible for initiating tumorigenesis and metastasis. We thus developed a novel RNAi…
very less number of somatic exonic Indel mutations for each tumor. From the previously reported candidate driver genes for PDAC's, we extensively observed large number of mutations in BRCA1 ... genes were relatively…